CTC
BIO icon

Central Trust Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Central Trust Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12
Closed -$4.15K – 1411
2024
Q1 		$4.15K Hold
12
– – ﹤0.01% 1189
2023
Q4 		$3.88K Buy
+12
New +$3.76K ﹤0.01% 1198
2023
Q3 		– Sell
-23
Closed -$8.72K – 1358
2023
Q2 		$8.72K Sell
23
-106
-82% -$43.1K ﹤0.01% 1042
2023
Q1 		$61.8K Sell
129
-6
-4% -$2.81K ﹤0.01% 749
2022
Q4 		$56.8K Sell
135
-395
-75% -$159K ﹤0.01% 748
2022
Q3 		$221K Sell
530
-19
-3% -$9.47K 0.01% 506
2022
Q2 		$272K Buy
549
+11
+2% +$5.73K 0.01% 474
2022
Q1 		$303K Sell
538
-7
-1% -$4.22K 0.01% 487
2021
Q4 		$412K Sell
545
-115
-17% -$86.1K 0.01% 468
2021
Q3 		$492K Sell
660
-35
-5% -$26.2K 0.02% 419
2021
Q2 		$448K Sell
695
-11
-2% -$6.7K 0.02% 423
2021
Q1 		$403K Sell
706
-90
-11% -$53.3K 0.02% 414
2020
Q4 		$464K Sell
796
-41
-5% -$23.4K 0.02% 376
2020
Q3 		$431K Sell
837
-39
-4% -$19.8K 0.02% 352
2020
Q2 		$396K Sell
876
-1,182
-57% -$522K 0.02% 355
2020
Q1 		$721K Sell
2,058
-4
-0.2% -$1.47K 0.04% 264
2019
Q4 		$763K Hold
2,062
– – 0.04% 292
2019
Q3 		$686K Buy
2,062
+2,042
+10,210% +$666K 0.04% 292
2019
Q2 		$6K Buy
20
+4
+25% +$1.2K ﹤0.01% 1019
2019
Q1 		$5K Buy
+16
New +$4.32K ﹤0.01% 992

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Central Trust Company's BIO Position: Q2 2024 in Review

Central Trust Company sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 12 shares — an estimated $4.15K sold.

Central Trust Company first reported a position in BIO in Q1 2019 and held it in 20 quarters. The position peaked at $763K in Q4 2019. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Central Trust Company reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Central Trust Company sold 12 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $4.15K.
  • Central Trust Company first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 20 quarters.
  • Central Trust Company's Bio-Rad Laboratories Class A position peaked at $763K in Q4 2019.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Central Trust Company's 13F filing for Q2 2024, filed 5 Aug 2024.